Cargando…
SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
The ongoing SARS-CoV-2 pandemic has led to the focused application of resources and scientific expertise toward the goal of developing investigational vaccines to prevent COVID-19. The highly collaborative global efforts by private industry, governments and non-governmental organizations have result...
Autores principales: | Chakraborty, Saborni, Mallajosyula, Vamsee, Tato, Cristina M., Tan, Gene S., Wang, Taia T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816567/ https://www.ncbi.nlm.nih.gov/pubmed/33482248 http://dx.doi.org/10.1016/j.addr.2021.01.014 |
Ejemplares similares
-
Schistosomiasis vaccines: where do we stand?
por: Tebeje, Biniam Mathewos, et al.
Publicado: (2016) -
Vaccine for Diabetes—Where Do We Stand?
por: Chellappan, Dinesh Kumar, et al.
Publicado: (2022) -
Mechanical Thrombectomy- Where Do We Stand Now ?
por: Chakraborty, Debabrata, et al.
Publicado: (2022) -
Where Do We Stand?
Publicado: (1891) -
Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?
por: Joshi, Gaurav, et al.
Publicado: (2021)